Citations 1
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).
Ciombor, Kristen K. , Salem, Mohamed E. , Nimeiri, Halla , Iqbal, Syma , Polite, Blasé N. , Deming, Dustin A. , Chan, Emily , Wade, James L. , Uronis, Hope E. , Pasia, Manolo , Bland, Gail L., Wolff, Robert A. , Ohinata, Aki, Ohaji, Chimela, Rogers, Jane E. , Sharma, Padmanee , Morris, Van K. , Singh, Preet Paul , Bekaii‐Saab, Tanios , Eng, Cathy , Rogers, Jane E
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3503-3503
